The relationshivs between nrenatal metboflnne dosaqe and the scveritv o f subsequent neonatal ~e t h a d o n c withdrawal t w r e studied in ?: ! clinicallv voll, methadone-maintained women an" 1 0 drtin-frec controls. Total methadone innestion durino tho last tripester, the last methadone dnse prior t o aaliverv and the absence of other druss o f ahusc were known. The nuantities o f methadone in intraparturn maternal hlood an? urine, amniotic fluid, cord hlood and n e m a t a l urinc *.ere determine? anrl thr? scveritv o* neonatal withdrawal w a s quantitated.
Severity of t'ithdravral <,?as related to last naternal dnse o f netkadnnc ( D ~c .~l ) , total amount inoesterl r'urino the last t r i m e~t r r (n c O . O Z ) , an< intraoartun maternal scrim metllac!ane (n i n.01.). Severitv w a s n o t related t o levels o f m~t h r s o n c in matcrnal urine, cord blood, amniotic fluid n r nconotal urine.
These findinos indicate that careeul ronitor- In a progressive study, 231 gravid females and their progeny were monitored to assess drug utilization during the perinatal period. The patients came from a middle to high socioeconomic population and delivered in a university hospital. Gravid patients were found to take a mean (M) of 9.6 drug preparations (DP) during the prenatal course with a range of 1-37; 6.4 DP (R-0-28) were prescription drugs; 3.2 DP (R-0-12) were over the counter drugs; and .03 drugs (R-0-3) were not identified. Twentyfive percent of patients received a drug chronically throughout pregnancy. Ninety percent were prescribed. The mother received a M -6.0 (R-0-14) drugs during labor and delivery. Single drugs were administered during LhD, whereas DP containing multiple agents were ingested during the prenatal course. During the post partum course the mother received a M -8.7 drug preparations (R-1-25).
Thirty-nine percent of the mothers were discharged home on medications. Fifty-nine percent of the mothers who were breast feeding were sent home on medications. During the nursery stay the progeny received a M -3.1 drugs (R-1-15) with 23% of the infants receiving 4-15. In infants who received >6 drugs. 40% were treated because of a direct or indirect effect of maternal drugs. Within the first natal days the average newborn infant had been exposed to a M = 18.7 drugs by intrauterine or extrauterine exposure. Breast fed infants may be exposed to an additional 7.7 (R-2-15) drugs. Gentamicin has been detected in serum of adult patients long after the drug has been discontinued and is the result of tissue accumulation. A prospective study was designed to see if this occurs in neonates. Twelve patients were treated with gentamicin 2.5 mglkg every twelve hours in combination with ampicillin for suspected or confirmed sepsis. Serum concentrations were measured throughout the duration of therapy and also after cessation of therapy for up to 28 days. Microbiological assay and radioinnnunoassay were employed to determine serum levels. Analysis of the first four patients revealed mean serum concentrations of gentamicin at one hour after injection of 10.0. 7.5, 7.4 and 5.6 mcg/ml. At eleven hours after injection mean serum concentrations were 1.9. 2.2, 2.7 and 1.6 mcg/rnl. Elimination rate constants calculated from these values do not account for the concentrations of 0.40 -0.01 mcglml that were j y d in serum for 2 -28 days after entamicin was discontinued. s persistence o f gentamicin For prolonged periods after cessation of therapy is due to the slow egress from a deep tissue compartment. 
----
Children's Hospital, Dept. of Pediatrics, St. Louis. Mo. 6 infants with mepivacaine intoxication secondary to accidental injection into the infant during paracervical and pudendal blocks were studied. All had depression at birth, tonic seizures with apnea in the first 6 hrs., and often unreactive dilated pupils. Two required respiratory support. Peak serum mepivacaine conc. were 9 to 25 uglml within the first 12 hrs. with a post-natal increase from cord and maternal conc. documented in 3 cases. CSF conc. was similar to simultaneous serum conc. Exchange transfusions in cases 3. 4, and 5 produced no significant changes in clinical status or serum conc., and the total removed by exchange was 3.5 mg in case 4 and 1.07 mg in case 5. Although gastric conc. on drainage reached 229 uglml in case 5 and 82 uglml in case 6, gastric lavage in case 6 recovered only 0.3 mg total. Urinary excretion under forced diuresis in cases 4, 5, and 6 produced 12.7 mg, 37.4 mg and 12.1 mg in the first 24 hrs. (80-90% of the total excreted in urine over 90 hrs). Thus, forced diuresis is the treatment of choice with gastric lavage and exchange transfusion used only when forced diuresis is contraindicated.
All 5 survivors were followed, 4 for 2 to 4 yrs, and are neurologically and developmentally normal. Anticonvulsants were discontinued in all. 3 at discharge. Early recognition, seizure control, and prompt resuscitation with carefully monitored respiratory support were key. If severe perinatal hypoxia can be avoided the prognosis from intoxication per se is excellent. Leadingestion produces profound alterations in liver morphologyand enzyme levels, as well as plasma protein composition in newbornrats. Seven day old rats were given 0.5ml 1% lead acetate bygastric tube daily x 7 and sacrificed. h%en compared to litter matecontrols,lead resulted in significant weight loss (19.6 f 3.5 vs24.3 ? 2.0gm) (m f SD);anemia (tict 24.2 f 1.9 vs 31.3 f 4.4%); kidney enlargement (0.37 ? 0.08 vs 0.28 t 0.07gm);and encephalopathy (cerebellar hemorrhage).Examination of liver showed no change in liver weight,protein content or DNA and RNA synthesis (3~-thymidine and uridine incorporation) .Hepatic UDP-glucuronyl transferase(GT)activity increased 69% in the lead treated newborn rats(1662 ? 301 vs 982 ? 207yM bilirubinlgm/40min).Lead treated adult rats showed a similar significant increase in GT activity (1864-+ 122 vs 1181 -+ 17211M/gm/40min).Likewise y-glutamyl transpeptidaseactivity was significantly increased in both newborn and adultrats.Ana1ysis of plasma proteins showed a lead induced increaseof 84% in albumin (2.3 ? 0.7 vs 1.3 ? 0.5gmld1);116% increasein transferrin (12.1 t 1.9 vs 5.6 f 2.2mglml);and 74% decreasein hemopexin (0.51 f 0.38 vs 1.96 f 0.88mg/ml).Morphologically.lead produced ultrastructural alterations in endoplasmic reticulumand the appearance of lamellar membranous bodies.GT is a membrane-boundenz e which is activated b sulfh dryl-blocking agents and phosphoEpases.~ead,by binding To sulfXydryl groups and disrupting microsomal membranes may exert similar metabolic effects by "unmasking" active enzyme sites.
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